Abstract

Occasionally there are explosive outbreaks of infectious diseases worldwide and they occur without any immediate epidemiological or microbiological explanations. Some of the bacterial infections that are often considered to be epidemic-prone are plague, cholera and Streptococcus infections. Continuous research works are done in search for potential medications that could increase the medical arsenal against these types of diseases. Our present work is focused upon repurposing the drugs: ciprofloxacin, norfloxacin, moxifloxacin, diltiazem against Streptococcus infections in blood, on skin, and in throat. We are hopeful that our finding will enrich the rational drug design against Streptococcus infections.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call